Mehra, Mandeep R.

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 6,358

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

Cited by 3,185

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie, C. J., Milani, R. V., Mehra, M. R., & Ventura, H. O. (2009) · Journal of the American College of Cardiology

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 644

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Mehra, M. R., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet

COVID-19 Clinical Research StudiesAcademic Publishing and Open Access

Cited by 553

Obesity and suppressed B-type natriuretic peptide levels in heart failure

Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 534

Body composition and prognosis in chronic systolic heart failure: the obesity paradox

Lavie, C. J., Osman, A. F., Milani, R. V., & Mehra, M. R. (2003) · The American Journal of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 486

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine

Heart Failure Treatment and ManagementAtrial Fibrillation Management and Outcomes

Cited by 345

Reduction in C-reactive protein through cardiac rehabilitation and exercise training

Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology

Cardiac Health and Mental HealthLipoproteins and Cardiovascular Health

Cited by 302

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure

Viral Infections and Immunology ResearchTransplantation: Methods and Outcomes

Cited by 219

Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction

Lavie, C. J., Milani, R. V., Ventura, H. O., Cardenas, G. A., Mehra, M. R., & Messerli, F. H. (2007) · The American Journal of Cardiology

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 131

Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure

Mehra, M. R., Lavie, C. J., Ventura, H. O., & Milani, R. V. (2006) · The Journal of Heart and Lung Transplantation

Fatty Acid Research and HealthHeart Failure Treatment and Management

Cited by 122